The Quidel Cardiovascular Detection System is a diagnostic platform designed for rapid and accurate cardiovascular biomarker testing in laboratory and point-of-care settings. This system delivers real-time results to support clinical decision-making for cardiac risk assessment and patient management...
Manufactured by
Quidel China Ltd.
China
Quidel Corporation (NASDAQ: QDEL) is a US-based medical diagnostics company founded in 1979, with core competencies in immunoassay technology, automated manufacturing, monoclonal antibody development, and molecular diagnostics. Quidel China, established in 2018, markets cardiac biomarker testing systems (Triage MeterPro), BNP assays for Beckman platforms, and Sofia respiratory virus detection instruments with associated reagents for Influenza A/B and RSV.
© 2026 Suplivia · Home · Browse Products